TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Cell & Gene Therapy Quality Control Market Poised USD 22.81 Billion at 25.74% CAGR by 2034

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Towards Healthcare
Cell & Gene Therapy Quality Control Market Poised USD 22.81 Billion at 25.74% CAGR by 2034

The global cell and gene therapy quality control market is projected to grow from $2.87 billion in 2025 to $22.81 billion by 2034, with a 25.74% CAGR. North America currently leads the market, while Asia Pacific is expected to witness the fastest growth, driven by technological advancements and increasing demand for personalized therapies.

Insights
BRO   neutral

Listed as a top holding with $202.3 million allocation, no specific performance details provided


TMO   positive

Listed as a key market player with strong presence in cell and gene therapy quality control market